| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | granulocyte colony-stimulating factor receptor binding | 1.36e-12 | 14 | 58 | 6 | GO:0005130 | |
| GeneOntologyMolecularFunction | GPI anchor binding | 4.47e-11 | 23 | 58 | 6 | GO:0034235 | |
| GeneOntologyMolecularFunction | monocarboxylic acid transmembrane transporter activity | 1.98e-10 | 90 | 58 | 8 | GO:0008028 | |
| GeneOntologyMolecularFunction | filamin binding | 2.08e-10 | 29 | 58 | 6 | GO:0031005 | |
| GeneOntologyMolecularFunction | Toll-like receptor binding | 2.08e-10 | 29 | 58 | 6 | GO:0035325 | |
| GeneOntologyMolecularFunction | bile acid transmembrane transporter activity | 5.81e-10 | 34 | 58 | 6 | GO:0015125 | |
| GeneOntologyMolecularFunction | lipid transmembrane transporter activity | 1.68e-09 | 73 | 58 | 7 | GO:0170055 | |
| GeneOntologyMolecularFunction | glycolipid binding | 5.84e-09 | 49 | 58 | 6 | GO:0051861 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 7.97e-09 | 207 | 58 | 9 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 8.31e-09 | 208 | 58 | 9 | GO:0005342 | |
| GeneOntologyMolecularFunction | organic hydroxy compound transmembrane transporter activity | 5.23e-08 | 70 | 58 | 6 | GO:1901618 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | 1.58e-07 | 293 | 58 | 9 | GO:0008514 | |
| GeneOntologyMolecularFunction | lipid transporter activity | 1.55e-06 | 196 | 58 | 7 | GO:0005319 | |
| GeneOntologyMolecularFunction | calmodulin binding | 4.48e-06 | 230 | 58 | 7 | GO:0005516 | |
| GeneOntologyMolecularFunction | protein tyrosine kinase binding | 4.59e-06 | 149 | 58 | 6 | GO:1990782 | |
| GeneOntologyMolecularFunction | growth factor receptor binding | 1.08e-05 | 173 | 58 | 6 | GO:0070851 | |
| GeneOntologyMolecularFunction | protein heterodimerization activity | 1.86e-05 | 398 | 58 | 8 | GO:0046982 | |
| GeneOntologyMolecularFunction | protein homodimerization activity | 1.93e-05 | 815 | 58 | 11 | GO:0042803 | |
| GeneOntologyMolecularFunction | protein phosphatase binding | 3.23e-05 | 210 | 58 | 6 | GO:0019903 | |
| GeneOntologyMolecularFunction | phosphatidylinositol binding | 3.50e-05 | 316 | 58 | 7 | GO:0035091 | |
| GeneOntologyMolecularFunction | cytokine receptor binding | 4.10e-05 | 324 | 58 | 7 | GO:0005126 | |
| GeneOntologyMolecularFunction | actin binding | 6.92e-05 | 479 | 58 | 8 | GO:0003779 | |
| GeneOntologyMolecularFunction | phosphatase binding | 1.15e-04 | 264 | 58 | 6 | GO:0019902 | |
| GeneOntologyMolecularFunction | protein dimerization activity | MYOM1 PSG2 PSG3 PSG4 PSG5 PSG11 PSG8 TAF1 LCT TENM2 TRIM37 ALPG | 1.48e-04 | 1205 | 58 | 12 | GO:0046983 |
| GeneOntologyMolecularFunction | hydrolase activity, hydrolyzing O-glycosyl compounds | 2.29e-04 | 103 | 58 | 4 | GO:0004553 | |
| GeneOntologyMolecularFunction | hydrolase activity, acting on glycosyl bonds | 8.14e-04 | 144 | 58 | 4 | GO:0016798 | |
| GeneOntologyMolecularFunction | glucosidase activity | 8.50e-04 | 15 | 58 | 2 | GO:0015926 | |
| GeneOntologyMolecularFunction | phospholipid binding | 1.01e-03 | 548 | 58 | 7 | GO:0005543 | |
| GeneOntologyMolecularFunction | SUMO ligase activity | 1.52e-03 | 20 | 58 | 2 | GO:0061665 | |
| GeneOntologyMolecularFunction | transmembrane transporter activity | 1.95e-03 | 1180 | 58 | 10 | GO:0022857 | |
| GeneOntologyMolecularFunction | acyl-CoA binding | 2.58e-03 | 26 | 58 | 2 | GO:0120227 | |
| GeneOntologyMolecularFunction | transporter activity | 3.70e-03 | 1289 | 58 | 10 | GO:0005215 | |
| GeneOntologyMolecularFunction | cytoskeletal protein binding | 4.19e-03 | 1099 | 58 | 9 | GO:0008092 | |
| GeneOntologyMolecularFunction | SUMO transferase activity | 4.90e-03 | 36 | 58 | 2 | GO:0019789 | |
| GeneOntologyMolecularFunction | solute:monoatomic cation symporter activity | 5.02e-03 | 119 | 58 | 3 | GO:0015294 | |
| GeneOntologyMolecularFunction | ubiquitin conjugating enzyme activity | 5.17e-03 | 37 | 58 | 2 | GO:0061631 | |
| GeneOntologyMolecularFunction | kinase binding | 6.65e-03 | 969 | 58 | 8 | GO:0019900 | |
| GeneOntologyMolecularFunction | ubiquitin-like protein conjugating enzyme activity | 6.94e-03 | 43 | 58 | 2 | GO:0061650 | |
| GeneOntologyMolecularFunction | lipid binding | 7.44e-03 | 988 | 58 | 8 | GO:0008289 | |
| GeneOntologyBiologicalProcess | negative regulation of brown fat cell proliferation | 1.12e-12 | 14 | 58 | 6 | GO:0070348 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immune response to tumor cell | 1.86e-12 | 15 | 58 | 6 | GO:0002856 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 1.86e-12 | 15 | 58 | 6 | GO:0002859 | |
| GeneOntologyBiologicalProcess | regulation of brown fat cell proliferation | 1.86e-12 | 15 | 58 | 6 | GO:0070347 | |
| GeneOntologyBiologicalProcess | positive regulation of homophilic cell adhesion | 1.86e-12 | 15 | 58 | 6 | GO:1903387 | |
| GeneOntologyBiologicalProcess | insulin receptor internalization | 2.97e-12 | 16 | 58 | 6 | GO:0038016 | |
| GeneOntologyBiologicalProcess | brown fat cell proliferation | 4.58e-12 | 17 | 58 | 6 | GO:0070342 | |
| GeneOntologyBiologicalProcess | granulocyte colony-stimulating factor signaling pathway | 4.58e-12 | 17 | 58 | 6 | GO:0038158 | |
| GeneOntologyBiologicalProcess | insulin catabolic process | 4.58e-12 | 17 | 58 | 6 | GO:1901143 | |
| GeneOntologyBiologicalProcess | regulation of homophilic cell adhesion | 6.85e-12 | 18 | 58 | 6 | GO:1903385 | |
| GeneOntologyBiologicalProcess | negative regulation of hepatocyte proliferation | 1.42e-11 | 20 | 58 | 6 | GO:2000346 | |
| GeneOntologyBiologicalProcess | negative regulation of response to tumor cell | 1.99e-11 | 21 | 58 | 6 | GO:0002835 | |
| GeneOntologyBiologicalProcess | negative regulation of immune response to tumor cell | 1.99e-11 | 21 | 58 | 6 | GO:0002838 | |
| GeneOntologyBiologicalProcess | negative regulation of fat cell proliferation | 1.99e-11 | 21 | 58 | 6 | GO:0070345 | |
| GeneOntologyBiologicalProcess | negative regulation of granulocyte differentiation | 2.73e-11 | 22 | 58 | 6 | GO:0030853 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet aggregation | 3.69e-11 | 23 | 58 | 6 | GO:0090331 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity directed against tumor cell target | 3.69e-11 | 23 | 58 | 6 | GO:0002858 | |
| GeneOntologyBiologicalProcess | positive regulation of vasculogenesis | 4.90e-11 | 24 | 58 | 6 | GO:2001214 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immune response to tumor cell | 4.90e-11 | 24 | 58 | 6 | GO:0002855 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity directed against tumor cell target | 4.90e-11 | 24 | 58 | 6 | GO:0002420 | |
| GeneOntologyBiologicalProcess | common myeloid progenitor cell proliferation | 6.44e-11 | 25 | 58 | 6 | GO:0035726 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immune response to tumor cell | 6.44e-11 | 25 | 58 | 6 | GO:0002423 | |
| GeneOntologyBiologicalProcess | regulation of fat cell proliferation | 1.07e-10 | 27 | 58 | 6 | GO:0070344 | |
| GeneOntologyBiologicalProcess | negative regulation of homotypic cell-cell adhesion | 1.36e-10 | 28 | 58 | 6 | GO:0034111 | |
| GeneOntologyBiologicalProcess | regulation of vasculogenesis | 1.71e-10 | 29 | 58 | 6 | GO:2001212 | |
| GeneOntologyBiologicalProcess | negative regulation of platelet activation | 2.64e-10 | 31 | 58 | 6 | GO:0010544 | |
| GeneOntologyBiologicalProcess | regulation of blood vessel remodeling | 3.24e-10 | 32 | 58 | 6 | GO:0060312 | |
| GeneOntologyBiologicalProcess | negative regulation of bone resorption | 3.24e-10 | 32 | 58 | 6 | GO:0045779 | |
| GeneOntologyBiologicalProcess | fat cell proliferation | 3.24e-10 | 32 | 58 | 6 | GO:0070341 | |
| GeneOntologyBiologicalProcess | negative regulation of feeding behavior | 3.96e-10 | 33 | 58 | 6 | GO:2000252 | |
| GeneOntologyBiologicalProcess | regulation of granulocyte differentiation | 3.96e-10 | 33 | 58 | 6 | GO:0030852 | |
| GeneOntologyBiologicalProcess | negative regulation of vascular permeability | 4.79e-10 | 34 | 58 | 6 | GO:0043116 | |
| GeneOntologyBiologicalProcess | negative regulation of bone remodeling | 4.79e-10 | 34 | 58 | 6 | GO:0046851 | |
| GeneOntologyBiologicalProcess | insulin metabolic process | 5.77e-10 | 35 | 58 | 6 | GO:1901142 | |
| GeneOntologyBiologicalProcess | regulation of hepatocyte proliferation | 9.76e-10 | 38 | 58 | 6 | GO:2000345 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid biosynthetic process | 1.15e-09 | 39 | 58 | 6 | GO:0045717 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated cytotoxicity | 1.35e-09 | 40 | 58 | 6 | GO:0045953 | |
| GeneOntologyBiologicalProcess | negative regulation of natural killer cell mediated immunity | 1.58e-09 | 41 | 58 | 6 | GO:0002716 | |
| GeneOntologyBiologicalProcess | regulation of platelet aggregation | 1.84e-09 | 42 | 58 | 6 | GO:0090330 | |
| GeneOntologyBiologicalProcess | negative regulation of behavior | 2.84e-09 | 45 | 58 | 6 | GO:0048521 | |
| GeneOntologyBiologicalProcess | epithelial cell proliferation involved in liver morphogenesis | 3.25e-09 | 46 | 58 | 6 | GO:0072575 | |
| GeneOntologyBiologicalProcess | hepatocyte proliferation | 3.25e-09 | 46 | 58 | 6 | GO:0072574 | |
| GeneOntologyBiologicalProcess | bile acid and bile salt transport | 3.72e-09 | 47 | 58 | 6 | GO:0015721 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated cytotoxicity | 3.72e-09 | 47 | 58 | 6 | GO:0001911 | |
| GeneOntologyBiologicalProcess | negative regulation of tissue remodeling | 3.72e-09 | 47 | 58 | 6 | GO:0034104 | |
| GeneOntologyBiologicalProcess | liver morphogenesis | 4.83e-09 | 49 | 58 | 6 | GO:0072576 | |
| GeneOntologyBiologicalProcess | regulation of immune response to tumor cell | 4.83e-09 | 49 | 58 | 6 | GO:0002837 | |
| GeneOntologyBiologicalProcess | regulation of response to tumor cell | 5.47e-09 | 50 | 58 | 6 | GO:0002834 | |
| GeneOntologyBiologicalProcess | negative regulation of cell killing | 6.98e-09 | 52 | 58 | 6 | GO:0031342 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid transport | 7.75e-09 | 213 | 58 | 9 | GO:0015718 | |
| GeneOntologyBiologicalProcess | regulation of homotypic cell-cell adhesion | 7.85e-09 | 53 | 58 | 6 | GO:0034110 | |
| GeneOntologyBiologicalProcess | immune response to tumor cell | 1.10e-08 | 56 | 58 | 6 | GO:0002418 | |
| GeneOntologyBiologicalProcess | negative regulation of osteoclast differentiation | 1.52e-08 | 59 | 58 | 6 | GO:0045671 | |
| GeneOntologyBiologicalProcess | granulocyte differentiation | 1.69e-08 | 60 | 58 | 6 | GO:0030851 | |
| GeneOntologyBiologicalProcess | negative regulation of fatty acid metabolic process | 1.69e-08 | 60 | 58 | 6 | GO:0045922 | |
| GeneOntologyBiologicalProcess | regulation of feeding behavior | 1.87e-08 | 61 | 58 | 6 | GO:0060259 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 3.02e-08 | 66 | 58 | 6 | GO:0010543 | |
| GeneOntologyBiologicalProcess | negative regulation of innate immune response | 3.12e-08 | 114 | 58 | 7 | GO:0045824 | |
| GeneOntologyBiologicalProcess | regulation of endothelial cell differentiation | 3.31e-08 | 67 | 58 | 6 | GO:0045601 | |
| GeneOntologyBiologicalProcess | negative regulation of blood coagulation | 3.96e-08 | 69 | 58 | 6 | GO:0030195 | |
| GeneOntologyBiologicalProcess | regulation of bone resorption | 4.32e-08 | 70 | 58 | 6 | GO:0045124 | |
| GeneOntologyBiologicalProcess | negative regulation of hemostasis | 4.32e-08 | 70 | 58 | 6 | GO:1900047 | |
| GeneOntologyBiologicalProcess | regulation of vascular permeability | 4.71e-08 | 71 | 58 | 6 | GO:0043114 | |
| GeneOntologyBiologicalProcess | response to tumor cell | 4.71e-08 | 71 | 58 | 6 | GO:0002347 | |
| GeneOntologyBiologicalProcess | negative regulation of interleukin-1 production | 5.13e-08 | 72 | 58 | 6 | GO:0032692 | |
| GeneOntologyBiologicalProcess | negative regulation of coagulation | 5.13e-08 | 72 | 58 | 6 | GO:0050819 | |
| GeneOntologyBiologicalProcess | regulation of fatty acid biosynthetic process | 5.58e-08 | 73 | 58 | 6 | GO:0042304 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated cytotoxicity | 7.12e-08 | 76 | 58 | 6 | GO:0042269 | |
| GeneOntologyBiologicalProcess | regulation of bone remodeling | 9.70e-08 | 80 | 58 | 6 | GO:0046850 | |
| GeneOntologyBiologicalProcess | regulation of natural killer cell mediated immunity | 9.70e-08 | 80 | 58 | 6 | GO:0002715 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte mediated immunity | 1.21e-07 | 83 | 58 | 6 | GO:0002707 | |
| GeneOntologyBiologicalProcess | regulation of sprouting angiogenesis | 1.40e-07 | 85 | 58 | 6 | GO:1903670 | |
| GeneOntologyBiologicalProcess | negative regulation of myeloid leukocyte differentiation | 1.40e-07 | 85 | 58 | 6 | GO:0002762 | |
| GeneOntologyBiologicalProcess | regulation of epidermal growth factor receptor signaling pathway | 1.50e-07 | 86 | 58 | 6 | GO:0042058 | |
| GeneOntologyBiologicalProcess | energy homeostasis | 1.56e-07 | 144 | 58 | 7 | GO:0097009 | |
| GeneOntologyBiologicalProcess | blood vessel remodeling | 1.61e-07 | 87 | 58 | 6 | GO:0001974 | |
| GeneOntologyBiologicalProcess | negative regulation of lipid biosynthetic process | 2.10e-07 | 91 | 58 | 6 | GO:0051055 | |
| GeneOntologyBiologicalProcess | regulation of blood coagulation | 2.10e-07 | 91 | 58 | 6 | GO:0030193 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 2.11e-07 | 313 | 58 | 9 | GO:0098742 | |
| GeneOntologyBiologicalProcess | negative regulation of response to biotic stimulus | 2.16e-07 | 151 | 58 | 7 | GO:0002832 | |
| GeneOntologyBiologicalProcess | regulation of hemostasis | 2.39e-07 | 93 | 58 | 6 | GO:1900046 | |
| GeneOntologyBiologicalProcess | regulation of ERBB signaling pathway | 2.39e-07 | 93 | 58 | 6 | GO:1901184 | |
| GeneOntologyBiologicalProcess | platelet aggregation | 2.72e-07 | 95 | 58 | 6 | GO:0070527 | |
| GeneOntologyBiologicalProcess | negative regulation of leukocyte mediated immunity | 2.89e-07 | 96 | 58 | 6 | GO:0002704 | |
| GeneOntologyBiologicalProcess | regulation of coagulation | 2.89e-07 | 96 | 58 | 6 | GO:0050818 | |
| GeneOntologyBiologicalProcess | negative regulation of wound healing | 3.27e-07 | 98 | 58 | 6 | GO:0061045 | |
| GeneOntologyBiologicalProcess | bone resorption | 3.47e-07 | 99 | 58 | 6 | GO:0045453 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated cytotoxicity | 4.92e-07 | 105 | 58 | 6 | GO:0042267 | |
| GeneOntologyBiologicalProcess | negative regulation of T cell proliferation | 5.50e-07 | 107 | 58 | 6 | GO:0042130 | |
| GeneOntologyBiologicalProcess | natural killer cell mediated immunity | 6.14e-07 | 109 | 58 | 6 | GO:0002228 | |
| GeneOntologyBiologicalProcess | regulation of osteoclast differentiation | 8.86e-07 | 116 | 58 | 6 | GO:0045670 | |
| GeneOntologyBiologicalProcess | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules | 9.15e-07 | 63 | 58 | 5 | GO:0007157 | |
| GeneOntologyBiologicalProcess | homophilic cell adhesion via plasma membrane adhesion molecules | 9.16e-07 | 187 | 58 | 7 | GO:0007156 | |
| GeneOntologyBiologicalProcess | vasculogenesis | 9.79e-07 | 118 | 58 | 6 | GO:0001570 | |
| GeneOntologyBiologicalProcess | positive regulation of protein serine/threonine kinase activity | 1.13e-06 | 193 | 58 | 7 | GO:0071902 | |
| GeneOntologyBiologicalProcess | negative regulation of lymphocyte proliferation | 1.31e-06 | 124 | 58 | 6 | GO:0050672 | |
| GeneOntologyBiologicalProcess | regulation of leukocyte mediated cytotoxicity | 1.31e-06 | 124 | 58 | 6 | GO:0001910 | |
| GeneOntologyBiologicalProcess | homotypic cell-cell adhesion | 1.31e-06 | 124 | 58 | 6 | GO:0034109 | |
| GeneOntologyBiologicalProcess | regulation of myeloid cell differentiation | 1.37e-06 | 288 | 58 | 8 | GO:0045637 | |
| GeneOntologyBiologicalProcess | negative regulation of response to wounding | 1.44e-06 | 126 | 58 | 6 | GO:1903035 | |
| GeneOntologyCellularComponent | transforming growth factor beta ligand-receptor complex | 2.46e-12 | 16 | 57 | 6 | GO:0070021 | |
| GeneOntologyCellularComponent | adherens junction | 1.06e-07 | 212 | 57 | 8 | GO:0005912 | |
| GeneOntologyCellularComponent | lateral plasma membrane | 1.64e-07 | 90 | 57 | 6 | GO:0016328 | |
| GeneOntologyCellularComponent | ciliary membrane | 2.72e-07 | 98 | 57 | 6 | GO:0060170 | |
| GeneOntologyCellularComponent | basal plasma membrane | 4.55e-07 | 354 | 57 | 9 | GO:0009925 | |
| GeneOntologyCellularComponent | basal part of cell | 7.86e-07 | 378 | 57 | 9 | GO:0045178 | |
| GeneOntologyCellularComponent | transferase complex | PIAS4 SETD1A KBTBD6 PSG2 PSG3 PSG4 PSG5 PSG11 PSG8 TAF1 KBTBD7 TRIM37 F13B | 1.44e-06 | 963 | 57 | 13 | GO:1990234 |
| GeneOntologyCellularComponent | basolateral plasma membrane | 2.38e-06 | 320 | 57 | 8 | GO:0016323 | |
| GeneOntologyCellularComponent | serine/threonine protein kinase complex | 4.31e-06 | 157 | 57 | 6 | GO:1902554 | |
| GeneOntologyCellularComponent | T cell receptor complex | 5.35e-06 | 163 | 57 | 6 | GO:0042101 | |
| GeneOntologyCellularComponent | protein kinase complex | 6.82e-06 | 170 | 57 | 6 | GO:1902911 | |
| GeneOntologyCellularComponent | external side of plasma membrane | 1.04e-05 | 519 | 57 | 9 | GO:0009897 | |
| GeneOntologyCellularComponent | side of membrane | 2.05e-05 | 875 | 57 | 11 | GO:0098552 | |
| GeneOntologyCellularComponent | cell-cell junction | 2.91e-05 | 591 | 57 | 9 | GO:0005911 | |
| GeneOntologyCellularComponent | apical part of cell | 2.95e-05 | 592 | 57 | 9 | GO:0045177 | |
| GeneOntologyCellularComponent | transferase complex, transferring phosphorus-containing groups | 3.39e-05 | 335 | 57 | 7 | GO:0061695 | |
| GeneOntologyCellularComponent | plasma membrane signaling receptor complex | 4.47e-05 | 350 | 57 | 7 | GO:0098802 | |
| GeneOntologyCellularComponent | plasma membrane protein complex | 4.59e-05 | 785 | 57 | 10 | GO:0098797 | |
| GeneOntologyCellularComponent | apical plasma membrane | 4.97e-05 | 487 | 57 | 8 | GO:0016324 | |
| GeneOntologyCellularComponent | anchoring junction | 2.75e-04 | 976 | 57 | 10 | GO:0070161 | |
| GeneOntologyCellularComponent | brush border | 7.87e-04 | 152 | 57 | 4 | GO:0005903 | |
| GeneOntologyCellularComponent | receptor complex | 9.80e-04 | 581 | 57 | 7 | GO:0043235 | |
| GeneOntologyCellularComponent | cell projection membrane | 1.11e-03 | 431 | 57 | 6 | GO:0031253 | |
| GeneOntologyCellularComponent | histone methyltransferase complex | 1.13e-03 | 75 | 57 | 3 | GO:0035097 | |
| GeneOntologyCellularComponent | cell surface | 2.95e-03 | 1111 | 57 | 9 | GO:0009986 | |
| GeneOntologyCellularComponent | cluster of actin-based cell projections | 3.20e-03 | 223 | 57 | 4 | GO:0098862 | |
| GeneOntologyCellularComponent | methyltransferase complex | 3.20e-03 | 108 | 57 | 3 | GO:0034708 | |
| GeneOntologyCellularComponent | Cul3-RING ubiquitin ligase complex | 5.07e-03 | 39 | 57 | 2 | GO:0031463 | |
| MousePheno | decreased susceptibility to Coronaviridae infection induced morbidity/mortality | 1.62e-11 | 17 | 49 | 6 | MP:0031047 | |
| MousePheno | increased skeletal muscle triglyceride level | 7.04e-11 | 21 | 49 | 6 | MP:0031415 | |
| MousePheno | decreased fatty acid oxidation | 1.73e-10 | 24 | 49 | 6 | MP:0014172 | |
| MousePheno | increased abdominal fat pad weight | 3.78e-10 | 27 | 49 | 6 | MP:0009286 | |
| MousePheno | decreased susceptibility to Coronaviridae infection | 4.80e-10 | 28 | 49 | 6 | MP:0020950 | |
| MousePheno | abnormal skeletal muscle triglyceride level | 9.31e-10 | 31 | 49 | 6 | MP:0031413 | |
| MousePheno | decreased carbon dioxide production | 9.31e-10 | 31 | 49 | 6 | MP:0008964 | |
| MousePheno | decreased skeletal muscle cell glucose uptake | 2.03e-09 | 35 | 49 | 6 | MP:0031618 | |
| MousePheno | abnormal muscle triglyceride level | 2.43e-09 | 36 | 49 | 6 | MP:0031412 | |
| MousePheno | decreased muscle cell glucose uptake | 4.04e-09 | 39 | 49 | 6 | MP:0030022 | |
| MousePheno | decreased susceptibility to Riboviria infection induced morbidity/mortality | 8.62e-09 | 44 | 49 | 6 | MP:0031023 | |
| MousePheno | abnormal skeletal muscle cell glucose uptake | 1.30e-08 | 47 | 49 | 6 | MP:0031617 | |
| MousePheno | abnormal susceptibility to Coronaviridae infection | 1.69e-08 | 49 | 49 | 6 | MP:0020948 | |
| MousePheno | decreased cellular glucose uptake | 2.74e-08 | 53 | 49 | 6 | MP:0003926 | |
| MousePheno | abnormal fatty acid oxidation | 3.07e-08 | 54 | 49 | 6 | MP:0010953 | |
| MousePheno | decreased susceptibility to viral infection induced morbidity/mortality | 5.86e-08 | 60 | 49 | 6 | MP:0009790 | |
| MousePheno | abnormal lipid oxidation | 6.49e-08 | 61 | 49 | 6 | MP:0010951 | |
| MousePheno | increased insulin secretion | 8.69e-08 | 64 | 49 | 6 | MP:0003058 | |
| MousePheno | decreased respiratory quotient | 1.01e-07 | 110 | 49 | 7 | MP:0010379 | |
| MousePheno | abnormal muscle cell glucose uptake | 1.15e-07 | 67 | 49 | 6 | MP:0004130 | |
| MousePheno | abnormal carbon dioxide production | 1.15e-07 | 67 | 49 | 6 | MP:0008962 | |
| MousePheno | abnormal vascular wound healing | 1.93e-07 | 73 | 49 | 6 | MP:0004883 | |
| MousePheno | decreased oxygen consumption | 3.10e-07 | 79 | 49 | 6 | MP:0005290 | |
| MousePheno | polyphagia | 3.34e-07 | 80 | 49 | 6 | MP:0001433 | |
| MousePheno | decreased susceptibility to Riboviria infection | 3.87e-07 | 82 | 49 | 6 | MP:0020914 | |
| MousePheno | abnormal cellular glucose uptake | 1.41e-06 | 102 | 49 | 6 | MP:0003925 | |
| MousePheno | abnormal intestine morphology | GREB1L MEX3A MYO5B PSG2 PSG3 PSG4 PSG5 PSG11 SLC5A7 PSG8 PAX7 | 2.21e-06 | 546 | 49 | 11 | MP:0000477 |
| MousePheno | obese | 2.57e-06 | 113 | 49 | 6 | MP:0001261 | |
| MousePheno | abnormal respiratory quotient | 2.64e-06 | 178 | 49 | 7 | MP:0004129 | |
| MousePheno | decreased energy expenditure | 3.48e-06 | 119 | 49 | 6 | MP:0004890 | |
| MousePheno | decreased susceptibility to infection induced morbidity/mortality | 3.65e-06 | 120 | 49 | 6 | MP:0009786 | |
| MousePheno | decreased circulating triglyceride level | 4.54e-06 | 275 | 49 | 8 | MP:0002644 | |
| MousePheno | increased circulating leptin level | 4.63e-06 | 125 | 49 | 6 | MP:0005669 | |
| MousePheno | decreased susceptibility to viral infection | 4.63e-06 | 125 | 49 | 6 | MP:0002410 | |
| MousePheno | increased incidence of tumors by chemical induction | 9.26e-06 | 141 | 49 | 6 | MP:0004499 | |
| MousePheno | abnormal glycogen homeostasis | 1.05e-05 | 144 | 49 | 6 | MP:0005438 | |
| MousePheno | abnormal colon morphology | 1.42e-05 | 152 | 49 | 6 | MP:0000495 | |
| MousePheno | decreased triglyceride level | 2.52e-05 | 348 | 49 | 8 | MP:0005318 | |
| MousePheno | abnormal insulin secretion | 2.78e-05 | 171 | 49 | 6 | MP:0003564 | |
| MousePheno | increased incidence of induced tumors | 2.96e-05 | 173 | 49 | 6 | MP:0002021 | |
| MousePheno | abnormal endocrine pancreas secretion | 3.26e-05 | 176 | 49 | 6 | MP:0014195 | |
| MousePheno | abnormal gas homeostasis | 3.55e-05 | 600 | 49 | 10 | MP:0003948 | |
| MousePheno | abnormal pancreas secretion | 4.06e-05 | 183 | 49 | 6 | MP:0002694 | |
| MousePheno | abnormal susceptibility to Riboviria infection | 4.45e-05 | 186 | 49 | 6 | MP:0020912 | |
| MousePheno | increased food intake | 4.87e-05 | 189 | 49 | 6 | MP:0011939 | |
| MousePheno | abnormal susceptibility to viral infection | 4.91e-05 | 279 | 49 | 7 | MP:0020185 | |
| MousePheno | abnormal wound healing | 5.47e-05 | 193 | 49 | 6 | MP:0005023 | |
| MousePheno | abnormal digestive system morphology | GREB1L MEX3A MOGS MYO5B PSG2 PSG3 PSG4 PSG5 PSG11 STAC3 TRPS1 SLC5A7 PSG8 PAX7 | 5.67e-05 | 1233 | 49 | 14 | MP:0000462 |
| MousePheno | abnormal skeletal muscle morphology | 5.78e-05 | 508 | 49 | 9 | MP:0000759 | |
| MousePheno | abnormal oxygen consumption | 5.79e-05 | 195 | 49 | 6 | MP:0005288 | |
| MousePheno | abnormal pancreatic beta cell physiology | 5.96e-05 | 196 | 49 | 6 | MP:0003562 | |
| MousePheno | insulin resistance | 6.13e-05 | 197 | 49 | 6 | MP:0005331 | |
| MousePheno | abnormal endocrine pancreas physiology | 7.04e-05 | 202 | 49 | 6 | MP:0010147 | |
| MousePheno | increased total body fat amount | 1.02e-04 | 424 | 49 | 8 | MP:0010024 | |
| MousePheno | digestive/alimentary phenotype | GREB1L MEX3A MOGS MYO5B PSG2 PSG3 PSG4 PSG5 TREH PSG11 STAC3 TRPS1 SLC5A7 PSG8 PAX7 | 1.23e-04 | 1500 | 49 | 15 | MP:0005381 |
| MousePheno | abnormal circulating leptin level | 1.66e-04 | 236 | 49 | 6 | MP:0005667 | |
| MousePheno | decreased lipid level | 1.76e-04 | 727 | 49 | 10 | MP:0014461 | |
| MousePheno | increased triglyceride level | 2.16e-04 | 354 | 49 | 7 | MP:0005317 | |
| MousePheno | decreased susceptibility to infection | 2.52e-04 | 255 | 49 | 6 | MP:0002409 | |
| MousePheno | abnormal endocrine gland physiology | 2.52e-04 | 363 | 49 | 7 | MP:0013561 | |
| MousePheno | increased total tissue mass | 2.57e-04 | 364 | 49 | 7 | MP:0012323 | |
| MousePheno | increased body weight | 2.57e-04 | 364 | 49 | 7 | MP:0001260 | |
| MousePheno | abnormal motor neuron innervation pattern | 2.89e-04 | 37 | 49 | 3 | MP:0000940 | |
| MousePheno | abnormal abdominal fat pad morphology | 2.91e-04 | 262 | 49 | 6 | MP:0000010 | |
| MousePheno | abnormal triglyceride level | 3.28e-04 | 639 | 49 | 9 | MP:0000187 | |
| MousePheno | abnormal incidence of induced tumors | 3.35e-04 | 269 | 49 | 6 | MP:0013151 | |
| MousePheno | abnormal large intestine morphology | 3.85e-04 | 276 | 49 | 6 | MP:0000489 | |
| MousePheno | abnormal circulating triglyceride level | 3.88e-04 | 516 | 49 | 8 | MP:0011969 | |
| MousePheno | abnormal susceptibility to infection induced morbidity/mortality | 4.07e-04 | 279 | 49 | 6 | MP:0009785 | |
| MousePheno | abnormal blood vessel physiology | 4.14e-04 | 394 | 49 | 7 | MP:0000249 | |
| MousePheno | increased circulating insulin level | 4.39e-04 | 283 | 49 | 6 | MP:0002079 | |
| MousePheno | increased physiological sensitivity to xenobiotic | 4.65e-04 | 286 | 49 | 6 | MP:0008873 | |
| MousePheno | abnormal vasculature physiology | 4.81e-04 | 404 | 49 | 7 | MP:0031170 | |
| MousePheno | increased body size | 5.18e-04 | 409 | 49 | 7 | MP:0001264 | |
| MousePheno | abnormal pancreas physiology | 5.19e-04 | 292 | 49 | 6 | MP:0002693 | |
| MousePheno | abnormal energy expenditure | 7.47e-04 | 313 | 49 | 6 | MP:0005450 | |
| MousePheno | abnormal fat pad morphology | 7.59e-04 | 314 | 49 | 6 | MP:0005334 | |
| MousePheno | abnormal energy homeostasis | 8.66e-04 | 322 | 49 | 6 | MP:0005448 | |
| MousePheno | abnormal muscle morphology | B4GAT1 PSG2 PSG3 PSG4 PSG5 PSG11 STAC3 PSG8 PAX7 RBM24 TRIM37 | 1.28e-03 | 1106 | 49 | 11 | MP:0002108 |
| MousePheno | impaired glucose tolerance | 1.33e-03 | 480 | 49 | 7 | MP:0005293 | |
| MousePheno | abnormal food intake | 1.34e-03 | 481 | 49 | 7 | MP:0005449 | |
| MousePheno | increased lean body mass | 1.41e-03 | 354 | 49 | 6 | MP:0003960 | |
| MousePheno | abnormal muscle physiology | 1.49e-03 | 954 | 49 | 10 | MP:0002106 | |
| MousePheno | abnormal neurotransmitter secretion | 1.66e-03 | 67 | 49 | 3 | MP:0005445 | |
| MousePheno | abnormal circulating insulin level | 1.77e-03 | 505 | 49 | 7 | MP:0001560 | |
| MousePheno | abnormal physiological response to xenobiotic | 1.95e-03 | 662 | 49 | 8 | MP:0008872 | |
| MousePheno | increased tumor incidence | 2.33e-03 | 530 | 49 | 7 | MP:0002020 | |
| MousePheno | abnormal consumption behavior | 2.65e-03 | 695 | 49 | 8 | MP:0002069 | |
| MousePheno | abnormal adipose tissue amount | 3.65e-03 | 1077 | 49 | 10 | MP:0005452 | |
| MousePheno | increased circulating hormone level | 3.78e-03 | 578 | 49 | 7 | MP:0014456 | |
| MousePheno | abnormal induced morbidity/mortality | 3.80e-03 | 737 | 49 | 8 | MP:0001657 | |
| MousePheno | thin diaphragm muscle | 4.00e-03 | 27 | 49 | 2 | MP:0000761 | |
| MousePheno | abnormal small intestine morphology | 4.11e-03 | 187 | 49 | 4 | MP:0000496 | |
| MousePheno | abnormal lean body mass | 4.19e-03 | 749 | 49 | 8 | MP:0003959 | |
| Domain | Ig_2 | 8.96e-08 | 73 | 57 | 6 | PF13895 | |
| Domain | ig | 1.74e-06 | 190 | 57 | 7 | PF00047 | |
| Domain | Immunoglobulin | 1.74e-06 | 190 | 57 | 7 | IPR013151 | |
| Domain | IGc2 | 7.07e-06 | 235 | 57 | 7 | SM00408 | |
| Domain | Ig_sub2 | 7.07e-06 | 235 | 57 | 7 | IPR003598 | |
| Domain | V-set | 2.01e-05 | 184 | 57 | 6 | PF07686 | |
| Domain | Ig_V-set | 3.13e-05 | 199 | 57 | 6 | IPR013106 | |
| Domain | zf-MIZ | 1.90e-04 | 7 | 57 | 2 | PF02891 | |
| Domain | ZF_SP_RING | 1.90e-04 | 7 | 57 | 2 | PS51044 | |
| Domain | Znf_MIZ | 2.53e-04 | 8 | 57 | 2 | IPR004181 | |
| Domain | IG | 2.81e-04 | 421 | 57 | 7 | SM00409 | |
| Domain | Ig_sub | 2.81e-04 | 421 | 57 | 7 | IPR003599 | |
| Domain | Kelch-typ_b-propeller | 6.32e-04 | 55 | 57 | 3 | IPR015915 | |
| Domain | 6-hairpin_glycosidase-like | 6.99e-04 | 13 | 57 | 2 | IPR008928 | |
| Domain | IG_LIKE | 7.06e-04 | 491 | 57 | 7 | PS50835 | |
| Domain | Kelch | 7.38e-04 | 58 | 57 | 3 | SM00612 | |
| Domain | Gal_Oxase/kelch_b-propeller | 7.76e-04 | 59 | 57 | 3 | IPR011043 | |
| Domain | Ig-like_dom | 8.13e-04 | 503 | 57 | 7 | IPR007110 | |
| Domain | BACK | 8.15e-04 | 60 | 57 | 3 | SM00875 | |
| Domain | BACK | 8.56e-04 | 61 | 57 | 3 | PF07707 | |
| Domain | BACK | 8.56e-04 | 61 | 57 | 3 | IPR011705 | |
| Domain | Kelch_1 | 1.28e-03 | 70 | 57 | 3 | PF01344 | |
| Domain | Kelch_1 | 1.28e-03 | 70 | 57 | 3 | IPR006652 | |
| Domain | - | 3.90e-03 | 663 | 57 | 7 | 2.60.40.10 | |
| Domain | Ig-like_fold | 5.48e-03 | 706 | 57 | 7 | IPR013783 | |
| Domain | - | 6.31e-03 | 39 | 57 | 2 | 2.120.10.30 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_MODIFICATION_SYNTHESIS_OF_GPI_ANCHORED_PROTEINS | 4.59e-08 | 99 | 49 | 7 | MM14624 | |
| Pathway | REACTOME_EXTRACELLULAR_MATRIX_ORGANIZATION | 2.66e-06 | 258 | 49 | 8 | MM14572 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 1.69e-05 | 158 | 49 | 6 | MM14812 | |
| Pathway | WP_EGFR1_SIGNALING_PATHWAY | 4.51e-05 | 188 | 49 | 6 | MM15828 | |
| Pathway | REACTOME_CELL_SURFACE_INTERACTIONS_AT_THE_VASCULAR_WALL | 5.37e-05 | 194 | 49 | 6 | M16312 | |
| Pathway | REACTOME_POST_TRANSLATIONAL_PROTEIN_MODIFICATION | PIAS4 SLC17A5 SEC16B B4GAT1 PSG2 PSG3 PSG4 PSG5 PSG11 PSMB1 PSG8 SCFD1 KBTBD7 ALPG | 1.87e-04 | 1389 | 49 | 14 | MM15307 |
| Pathway | BIOCARTA_FEEDER_PATHWAY | 4.20e-04 | 9 | 49 | 2 | M3061 | |
| Pubmed | Regulation of hepatic fibrosis by carcinoembryonic antigen-related cell adhesion molecule 1. | 2.80e-14 | 13 | 58 | 6 | 34058224 | |
| Pubmed | A mouse carcinoembryonic antigen gene family member is a calcium-dependent cell adhesion molecule. | 2.80e-14 | 13 | 58 | 6 | 1985902 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 15207636 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 19285068 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 21760897 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 1719235 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 10964771 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 32169849 | ||
| Pubmed | CEACAM1+ myeloid cells control angiogenesis in inflammation. | 2.80e-14 | 13 | 58 | 6 | 19273835 | |
| Pubmed | Mechanism of glucose intolerance in mice with dominant negative mutation of CEACAM1. | 2.80e-14 | 13 | 58 | 6 | 16638824 | |
| Pubmed | Mouse hepatitis virus utilizes two carcinoembryonic antigens as alternative receptors. | 2.80e-14 | 13 | 58 | 6 | 1326665 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 20044046 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 32150576 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 21081647 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 11133662 | ||
| Pubmed | Conditional deletion of CEACAM1 in hepatic stellate cells causes their activation. | 2.80e-14 | 13 | 58 | 6 | 39168268 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 22469976 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 11483763 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 6265583 | ||
| Pubmed | CEACAM1 creates a pro-angiogenic tumor microenvironment that supports tumor vessel maturation. | 2.80e-14 | 13 | 58 | 6 | 21532628 | |
| Pubmed | Structural and Molecular Evidence Suggesting Coronavirus-driven Evolution of Mouse Receptor. | 2.80e-14 | 13 | 58 | 6 | 28035001 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 34440862 | ||
| Pubmed | CEACAM1 is a potent regulator of B cell receptor complex-induced activation. | 2.80e-14 | 13 | 58 | 6 | 12832451 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 25406283 | ||
| Pubmed | Interaction between altered insulin and lipid metabolism in CEACAM1-inactive transgenic mice. | 2.80e-14 | 13 | 58 | 6 | 15316023 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 8402684 | ||
| Pubmed | Crystal structure of mouse coronavirus receptor-binding domain complexed with its murine receptor. | 2.80e-14 | 13 | 58 | 6 | 21670291 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 22162753 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 2164599 | ||
| Pubmed | In vivo adaptation and persistence of Neisseria meningitidis within the nasopharyngeal mucosa. | 2.80e-14 | 13 | 58 | 6 | 23935487 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 2702644 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 16619040 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 8380065 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 1279194 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 15331748 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 29377208 | ||
| Pubmed | Expression of MHV-A59 receptor glycoproteins in susceptible and resistant strains of mice. | 2.80e-14 | 13 | 58 | 6 | 8209741 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 22673933 | ||
| Pubmed | Tumor angiogenesis mediated by myeloid cells is negatively regulated by CEACAM1. | 2.80e-14 | 13 | 58 | 6 | 22406619 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 27002145 | ||
| Pubmed | Mice with null mutation of Ceacam I develop nonalcoholic steatohepatitis. | 2.80e-14 | 13 | 58 | 6 | 21949477 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 29396368 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 26219866 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 7628460 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 25724769 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 18003729 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 26284027 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 2133556 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 32521208 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 26374765 | ||
| Pubmed | CEACAM1 specifically suppresses B cell receptor signaling-mediated activation. | 2.80e-14 | 13 | 58 | 6 | 33352461 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 19406938 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 38381498 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 20739537 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 19621080 | ||
| Pubmed | Forced Hepatic Overexpression of CEACAM1 Curtails Diet-Induced Insulin Resistance. | 2.80e-14 | 13 | 58 | 6 | 25972571 | |
| Pubmed | CEACAM1 promotes CD8+ T cell responses and improves control of a chronic viral infection. | 2.80e-14 | 13 | 58 | 6 | 29967450 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 1633107 | ||
| Pubmed | Expression of newly identified secretory CEACAM1(a) isoforms in the intestinal epithelium. | 2.80e-14 | 13 | 58 | 6 | 19358828 | |
| Pubmed | The role of CEA-related cell adhesion molecule-1 (CEACAM1) in vascular homeostasis. | 2.80e-14 | 13 | 58 | 6 | 27695943 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 20404914 | ||
| Pubmed | CEACAM1 deficiency delays important wound healing processes. | 2.80e-14 | 13 | 58 | 6 | 22092845 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 16680193 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 11801635 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 26911181 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 1653760 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 28913658 | ||
| Pubmed | Hepatic CEACAM1 expression indicates donor liver quality and prevents early transplantation injury. | 2.80e-14 | 13 | 58 | 6 | 32027621 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 19008452 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 18544705 | ||
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 30664851 | ||
| Pubmed | Role for hepatic CEACAM1 in regulating fatty acid metabolism along the adipocyte-hepatocyte axis. | 2.80e-14 | 13 | 58 | 6 | 27777319 | |
| Pubmed | Expression of the mouse hepatitis virus receptor by central nervous system microglia. | 2.80e-14 | 13 | 58 | 6 | 15220458 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 18848945 | ||
| Pubmed | Expression of the Bgp gene and characterization of mouse colon biliary glycoprotein isoforms. | 2.80e-14 | 13 | 58 | 6 | 8500759 | |
| Pubmed | 2.80e-14 | 13 | 58 | 6 | 18843289 | ||
| Pubmed | Mouse susceptibility to mouse hepatitis virus infection is linked to viral receptor genotype. | 2.80e-14 | 13 | 58 | 6 | 9343248 | |
| Pubmed | Ceacam1 deletion causes vascular alterations in large vessels. | 2.80e-14 | 13 | 58 | 6 | 23800882 | |
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 37531413 | ||
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 23780386 | ||
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 28567513 | ||
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 8207827 | ||
| Pubmed | CEACAM1 regulates integrin αIIbβ3-mediated functions in platelets. | 4.90e-14 | 14 | 58 | 6 | 26196244 | |
| Pubmed | Human CEACAM1-LF regulates lipid storage in HepG2 cells via fatty acid transporter CD36. | 4.90e-14 | 14 | 58 | 6 | 34666041 | |
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 8896983 | ||
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 19700760 | ||
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 34619794 | ||
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 22962327 | ||
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 17623671 | ||
| Pubmed | Loss of CEACAM1 in endothelial cells causes hepatic fibrosis. | 4.90e-14 | 14 | 58 | 6 | 37088122 | |
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 26846848 | ||
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 14517298 | ||
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 23070997 | ||
| Pubmed | Expression patterns of CD66a and CD117 in the mouse submandibular gland. | 4.90e-14 | 14 | 58 | 6 | 25498293 | |
| Pubmed | Endothelial barrier function is differentially regulated by CEACAM1-mediated signaling. | 4.90e-14 | 14 | 58 | 6 | 29746166 | |
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 9212243 | ||
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 25908210 | ||
| Pubmed | 4.90e-14 | 14 | 58 | 6 | 9047385 | ||
| Pubmed | Ceacam1L Modulates STAT3 Signaling to Control the Proliferation of Glioblastoma-Initiating Cells. | 4.90e-14 | 14 | 58 | 6 | 26238781 | |
| Pubmed | CEACAM1 controls the EMT switch in murine mammary carcinoma in vitro and in vivo. | 4.90e-14 | 14 | 58 | 6 | 27572314 | |
| Interaction | PSG4 interactions | 3.99e-09 | 8 | 57 | 4 | int:PSG4 | |
| Interaction | PSG1 interactions | 1.30e-05 | 51 | 57 | 4 | int:PSG1 | |
| Cytoband | 19q13.2 | 2.15e-06 | 164 | 58 | 5 | 19q13.2 | |
| GeneFamily | CD molecules|V-set domain containing|Pregnancy specific glycoproteins | 5.76e-14 | 11 | 43 | 6 | 1315 | |
| GeneFamily | Adenosine receptors|V-set domain containing | 2.27e-06 | 163 | 43 | 6 | 590 | |
| GeneFamily | Zinc fingers MIZ-type | 1.15e-04 | 7 | 43 | 2 | 85 | |
| GeneFamily | Basic leucine zipper proteins|BTB domain containing | 3.96e-03 | 134 | 43 | 3 | 861 | |
| Coexpression | GIBBONS_GENETIC_MOUSE_MODEL_LUNG_ADENOCARCINOMA_DOWN_IN_METASTASIS | 7.80e-11 | 32 | 58 | 6 | MM2 | |
| Coexpression | OUYANG_PROSTATE_CANCER_MARKERS | 1.39e-10 | 35 | 58 | 6 | MM757 | |
| Coexpression | BYSTROEM_CORRELATED_WITH_IL5_DN | 3.15e-10 | 75 | 58 | 7 | MM605 | |
| Coexpression | WANG_RESPONSE_TO_BEXAROTENE_UP | 1.03e-09 | 48 | 58 | 6 | MM531 | |
| Coexpression | DESCARTES_FETAL_PLACENTA_TROPHOBLAST_GIANT_CELLS | 1.46e-09 | 93 | 58 | 7 | M40279 | |
| Coexpression | HOLLERN_EMT_BREAST_TUMOR_DN | 1.99e-08 | 135 | 58 | 7 | MM965 | |
| Coexpression | BOYLAN_MULTIPLE_MYELOMA_PCA3_DN | 3.96e-08 | 87 | 58 | 6 | MM851 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_4_5WK_UP | 2.06e-07 | 284 | 58 | 8 | MM987 | |
| Coexpression | OHGUCHI_LIVER_HNF4A_TARGETS_DN | 3.03e-07 | 201 | 58 | 7 | MM1294 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_12HR_UP | 3.96e-07 | 128 | 58 | 6 | MM1000 | |
| Coexpression | DESCARTES_FETAL_ADRENAL_CSH1_CSH2_POSITIVE_CELLS | 6.29e-07 | 224 | 58 | 7 | M40145 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_3_4WK_UP | 7.52e-07 | 230 | 58 | 7 | MM986 | |
| Coexpression | MCBRYAN_PUBERTAL_BREAST_5_6WK_UP | 7.61e-07 | 143 | 58 | 6 | MM989 | |
| Coexpression | ZHANG_BREAST_CANCER_PROGENITORS_DN | 1.41e-06 | 159 | 58 | 6 | MM760 | |
| Coexpression | MARTINEZ_RB1_AND_TP53_TARGETS_UP | 2.47e-06 | 689 | 58 | 10 | MM1041 | |
| Coexpression | MARTINEZ_TP53_TARGETS_UP | 2.63e-06 | 694 | 58 | 10 | MM1039 | |
| Coexpression | MCBRYAN_PUBERTAL_TGFB1_TARGETS_UP | 3.10e-06 | 182 | 58 | 6 | MM993 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_EPITHELIAL_CELL_AGEING | 4.09e-06 | 568 | 58 | 9 | MM3824 | |
| Coexpression | MARTINEZ_RB1_TARGETS_UP | 4.70e-06 | 741 | 58 | 10 | MM1037 | |
| Coexpression | BROWN_MYELOID_CELL_DEVELOPMENT_UP | 5.48e-06 | 201 | 58 | 6 | MM1006 | |
| Coexpression | TABULA_MURIS_SENIS_SUBCUTANEOUS_ADIPOSE_TISSUE_MYELOID_CELL_AGEING | 8.95e-06 | 219 | 58 | 6 | MM3826 | |
| Coexpression | TABULA_MURIS_SENIS_SKIN_BULGE_KERATINOCYTE_AGEING | 2.92e-05 | 915 | 58 | 10 | MM3828 | |
| Coexpression | DESCARTES_FETAL_EYE_PDE11A_FAM19A2_POSITIVE_CELLS | 3.61e-05 | 29 | 58 | 3 | M40183 | |
| Coexpression | DESCARTES_MAIN_FETAL_TROPHOBLAST_GIANT_CELLS | 3.86e-05 | 171 | 58 | 5 | M40134 | |
| Coexpression | LIM_MAMMARY_STEM_CELL_DN | 4.86e-05 | 436 | 58 | 7 | MM1326 | |
| Coexpression | ZHANG_UTERUS_C1_REGENERATIVE_UP | 5.45e-05 | 302 | 58 | 6 | MM16604 | |
| Coexpression | KUMAR_TARGETS_OF_MLL_AF9_FUSION | 7.09e-05 | 463 | 58 | 7 | MM1011 | |
| Coexpression | SCHAEFFER_PROSTATE_DEVELOPMENT_48HR_UP | 1.01e-04 | 490 | 58 | 7 | MM1001 | |
| Coexpression | SWEET_LUNG_CANCER_KRAS_UP | 1.71e-04 | 534 | 58 | 7 | MM1050 | |
| Coexpression | GSE6259_DEC205_POS_DC_VS_CD8_TCELL_DN | 3.80e-04 | 154 | 58 | 4 | M6776 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma-Keratinizing_Cervical_Squamous_Cell_Carcinoma-6|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.43e-08 | 136 | 58 | 6 | 2c723777fadc5946df67d3e992471d8134b827f4 | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 1.82e-07 | 191 | 58 | 6 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.06e-07 | 195 | 58 | 6 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 3.84e-06 | 181 | 58 | 5 | 719eb532453ab7cd7893726885bc75d74a10b21e | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.84e-06 | 181 | 58 | 5 | 47dce04db3392333eb2f7b9b24c32e6740d2d02f | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 3.84e-06 | 181 | 58 | 5 | 19103221c3a5a16b16378348004b2c50caee4f01 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.06e-06 | 183 | 58 | 5 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 4.16e-06 | 184 | 58 | 5 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.16e-06 | 184 | 58 | 5 | e737f0f14c49b07bbb04a165083ac32210bc5690 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.28e-06 | 185 | 58 | 5 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | PND07-28-samps-Mesenchymal-Myofibroblast-myofibroblast_-_mature_-_C|PND07-28-samps / Age Group, Lineage, Cell class and subclass | 4.28e-06 | 185 | 58 | 5 | 427176ad9ab8d9511200fb0a132cfd1e835fe35c | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.28e-06 | 185 | 58 | 5 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 4.75e-06 | 189 | 58 | 5 | 0a82931b5f6c0a6427ca3edd5e2235ac49099d40 | |
| ToppCell | RV-15._Ventricular_Cardiomyocyte_III|RV / Chamber and Cluster_Paper | 4.87e-06 | 190 | 58 | 5 | 93c3188dfeb0b2f9889f8ae9b9c1f2f34129c99b | |
| ToppCell | COVID-19-Heart|COVID-19 / Disease (COVID-19 only), tissue and cell type | 4.87e-06 | 190 | 58 | 5 | 918ad5037881212008f9f69d5df5da91fd01422c | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|LV / Chamber and Cluster_Paper | 4.99e-06 | 191 | 58 | 5 | 25f3eb34f4e70761e81e84c8a5829f216108cbc6 | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW19|fetalBrain_Zhong_nature / Sample Type, Dataset, Time_group, and Cell type. | 4.99e-06 | 191 | 58 | 5 | b5328733da3d3d77c4f6fc5e2ba2035f8898f172 | |
| ToppCell | LV-04._Ventricular_Cardiomyocyte_I|LV / Chamber and Cluster_Paper | 5.12e-06 | 192 | 58 | 5 | ad19e2c1d36a0566c9b12ced10db78f4781c8ea6 | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.25e-06 | 193 | 58 | 5 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 5.39e-06 | 194 | 58 | 5 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | COVID-19-Heart-CM_1|Heart / Disease (COVID-19 only), tissue and cell type | 5.52e-06 | 195 | 58 | 5 | f1ef50331eda8f1239dba6ea970df4eaccf032f1 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pvalb_(MGE-derived_cortical_interneurons--basket_cells)|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.37e-05 | 48 | 58 | 3 | b4338a4f976425ff055a3dea48b6c1e9d6b49bac | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pvalb_(MGE-derived_cortical_interneurons--basket_cells)--|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.37e-05 | 48 | 58 | 3 | 551be574263b25ef971ed9ea897f44707f1f2bb7 | |
| ToppCell | Frontal_cortex-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Inhibitory_Neuron.Gad1Gad2.Pvalb_(MGE-derived_cortical_interneurons--basket_cells)-|Frontal_cortex / BrainAtlas - Mouse McCarroll V32 | 3.37e-05 | 48 | 58 | 3 | 1bf16774cec498d4b2b99fcdc5a7a1c3bfec24b8 | |
| ToppCell | Adult-Mesenchymal-chondrocyte|Adult / Lineage, Cell type, age group and donor | 5.49e-05 | 159 | 58 | 4 | 3f7305ee76447064b5c846c4f576360a2f7e0b7c | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.64e-05 | 167 | 58 | 4 | 1adb566f98af0109c8cc6e36033b89651e2c75e7 | |
| ToppCell | facs-Lung-3m-Mesenchymal-fibroblast-mesothelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 6.64e-05 | 167 | 58 | 4 | 743df5908c1ceb43b34b240d9f9649f30f4142fa | |
| ToppCell | COVID-19-Heart-CM_+_Macrophage|COVID-19 / Disease (COVID-19 only), tissue and cell type | 7.12e-05 | 170 | 58 | 4 | 3f15242a1d3e4e9871d9170b2ef05842fb609c29 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2-Inhibitory_Neuron.Gad1Gad2.Pou6f2-Pax6_(Zona_incerta_(ZI))|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.28e-05 | 62 | 58 | 3 | 02f0398e18bd61fbfa03bce71ae77e106181abee | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2-Inhibitory_Neuron.Gad1Gad2.Pou6f2-Pax6_(Zona_incerta_(ZI))-|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.28e-05 | 62 | 58 | 3 | 8fdbced7a2baa1bfb5b1e204128234424a872fe6 | |
| ToppCell | Thalamus-Neuronal-Inhibitory-iN1(Gad1Gad2_Th)-Pou6f2|Thalamus / BrainAtlas - Mouse McCarroll V32 | 7.28e-05 | 62 | 58 | 3 | ff68e007b8b2af4c7fb09139aed92e86907a05da | |
| ToppCell | AT1_cells-Donor_03|World / lung cells shred on cell class, cell subclass, sample id | 7.62e-05 | 173 | 58 | 4 | 3afca2a429c634af0220c1aa19ce4cf4ee3e8b3e | |
| ToppCell | Fetal_brain-fetalBrain_Zhong_nature-GW10-Neuronal-GABAergic_neurons|GW10 / Sample Type, Dataset, Time_group, and Cell type. | 7.96e-05 | 175 | 58 | 4 | d4ff1f197ad4086286e86817cbff24fa718293fc | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell-Intercalated_Cell_Type_B|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.14e-05 | 176 | 58 | 4 | 6c7edf1cb38644500bce6c5a1dd90bbe17415cdb | |
| ToppCell | (3)_Chondrocytes-(32)_Chondro-prehyper-2|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 8.51e-05 | 178 | 58 | 4 | c569a406c3ae183a278d8540e8eba58f4f26c5b0 | |
| ToppCell | droplet-Limb_Muscle-nan-21m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 9.47e-05 | 183 | 58 | 4 | 6f5dbac2748f50105f0f548d189c42ef14287019 | |
| ToppCell | 10x3'2.3-week_12-13-Mesenchymal_myocytic-stroma-muscle|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 9.87e-05 | 185 | 58 | 4 | 0094f9baddb20214d2a2c166f1637d1a9cf1169a | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.05e-04 | 188 | 58 | 4 | 6d249fe92d51a19da19ec14bb2262d394255d577 | |
| ToppCell | facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 188 | 58 | 4 | a91443aa8fa8fa87f7501c59219daa0305bd0bbf | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_myocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 188 | 58 | 4 | 4db566f3f708e66730aa9e16f4d73d91dc534177 | |
| ToppCell | facs-Heart-Unknown-3m-Mesenchymal-ventricular_cardiomyocyte|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.05e-04 | 188 | 58 | 4 | 6704b92991ad8c0a910e9f36cd33d00bd26dcb8f | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 1.07e-04 | 189 | 58 | 4 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.07e-04 | 189 | 58 | 4 | 5e80c47f63980904c4c1ff02c201b67b456a0974 | |
| ToppCell | LV-06._Ventricular_Cardiomyocyte_II|World / Chamber and Cluster_Paper | 1.09e-04 | 190 | 58 | 4 | de5ef606a002f85c2e0e3a36c1f259d0b85a76ff | |
| ToppCell | P07|World / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.09e-04 | 190 | 58 | 4 | 38a613a9bca0ba040c3ada00286d1ce6f83ab23a | |
| ToppCell | RV-06._Ventricular_Cardiomyocyte_II|RV / Chamber and Cluster_Paper | 1.09e-04 | 190 | 58 | 4 | fe8e78922c8ae928ef9a80bffd67868d5a87a091 | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-30m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.12e-04 | 191 | 58 | 4 | f932980baa032748857cb367a55c37dd975c693e | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_myocytic-stroma-myofibroblast|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 1.16e-04 | 193 | 58 | 4 | 02dfd1df1e7fc84bfca2b0c95138b5b4408bb5d1 | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|World / Chamber and Cluster_Paper | 1.19e-04 | 194 | 58 | 4 | 89812fb164065041357bb37a3c2d87028ec3de4e | |
| ToppCell | droplet-Limb_Muscle-MUSCLE-1m-Mesenchymal-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.21e-04 | 195 | 58 | 4 | 0bdf845939bc4b8cc94f2808aea60f818425b076 | |
| ToppCell | PND07-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_airway-SCMF|PND07 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.23e-04 | 196 | 58 | 4 | f0fd7db22985d2bc84dc8bcbdb2d552e280121dd | |
| ToppCell | (2)_Fibroblasts-(23)_Fibro-4|(2)_Fibroblasts / Cell class and subclass of bone marrow stroma cells in homeostatis | 1.28e-04 | 198 | 58 | 4 | e0ef49ec0f87cc87b45efa297b9ff6c35b7a2ba9 | |
| ToppCell | Tracheal-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.28e-04 | 198 | 58 | 4 | 7a0c4dbc8c99968d42af00a718f4fedc544599ec | |
| ToppCell | Brain_organoid-organoid_Tanaka_cellReport-6m-Mesenchymal-Mesoderm|6m / Sample Type, Dataset, Time_group, and Cell type. | 1.33e-04 | 200 | 58 | 4 | 0f6851baf0cf2a8b0c95a7a585c4407c330c5f6c | |
| Computational | Neighborhood of CDKN1C | 1.97e-06 | 27 | 37 | 4 | GNF2_CDKN1C | |
| Computational | Neighborhood of EGFR | 3.99e-06 | 32 | 37 | 4 | GNF2_EGFR | |
| Computational | Neighborhood of IGFBP1 | 5.76e-06 | 35 | 37 | 4 | GNF2_IGFBP1 | |
| Computational | Neighborhood of MMP11 | 1.21e-05 | 42 | 37 | 4 | GNF2_MMP11 | |
| Computational | Neighborhood of TIMP2 | 1.75e-05 | 46 | 37 | 4 | GNF2_TIMP2 | |
| Computational | Neighborhood of KISS1 | 2.25e-05 | 49 | 37 | 4 | GNF2_KISS1 | |
| Drug | AC1L1IPV | 1.19e-09 | 43 | 58 | 6 | CID000004683 | |
| Drug | Rgd Peptide | 2.45e-06 | 239 | 58 | 7 | CID000104802 | |
| Drug | valiolamine | 4.41e-06 | 13 | 58 | 3 | CID000174312 | |
| Drug | AC1OAGYH | 6.98e-06 | 15 | 58 | 3 | CID006857622 | |
| Drug | galactomannan | 8.00e-06 | 50 | 58 | 4 | CID000439336 | |
| Drug | Clobetasol propionate [25122-46-7]; Up 200; 8.6uM; MCF7; HT_HG-U133A | 9.92e-06 | 194 | 58 | 6 | 6835_UP | |
| Drug | fagomine | 1.04e-05 | 17 | 58 | 3 | CID000072259 | |
| Drug | Succinylsulfathiazole [116-43-8]; Down 200; 11.2uM; MCF7; HT_HG-U133A | 1.11e-05 | 198 | 58 | 6 | 2821_DN | |
| Drug | NSC624987 | 2.33e-05 | 22 | 58 | 3 | CID000001472 | |
| Drug | ginsenoside | 2.68e-05 | 23 | 58 | 3 | CID000092797 | |
| Drug | nimbidiol | 3.81e-05 | 4 | 58 | 2 | ctd:C496111 | |
| Disease | cD177 antigen measurement | 4.03e-08 | 18 | 58 | 4 | EFO_0021866 | |
| Disease | pregnancy-specific beta-1-glycoprotein 3 measurement | 2.51e-07 | 7 | 58 | 3 | EFO_0801906 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 3 in blood serum | 3.80e-06 | 2 | 58 | 2 | OBA_2043058 | |
| Disease | level of pregnancy-specific beta-1-glycoprotein 4 in blood serum | 3.80e-06 | 2 | 58 | 2 | OBA_2043059 | |
| Disease | pregnancy-specific beta-1-glycoprotein 4 measurement | 5.67e-05 | 6 | 58 | 2 | EFO_0801907 | |
| Disease | alcohol consumption measurement | MAGI1 SETD1A EFNB3 RBFOX1 TRPS1 EIF4G1 P4HA3 SAMHD1 BIRC6 TENM2 | 1.39e-04 | 1242 | 58 | 10 | EFO_0007878 |
| Disease | cigarettes per day measurement | 2.18e-04 | 438 | 58 | 6 | EFO_0006525 | |
| Disease | MAJOR AFFECTIVE DISORDER 2 | 5.07e-04 | 17 | 58 | 2 | C1839839 | |
| Disease | Inborn Errors of Metabolism | 5.07e-04 | 17 | 58 | 2 | C0025521 | |
| Disease | health study participation | 5.94e-04 | 195 | 58 | 4 | EFO_0010130 | |
| Disease | nighttime rest measurement | 1.02e-03 | 24 | 58 | 2 | EFO_0007827 | |
| Disease | pulmonary embolism | 1.11e-03 | 25 | 58 | 2 | EFO_0003827 | |
| Disease | lifestyle measurement, maximum cigarettes per day measurement | 1.80e-03 | 122 | 58 | 3 | EFO_0009264, EFO_0010724 | |
| Disease | bitter non-alcoholic beverage consumption measurement | 1.81e-03 | 32 | 58 | 2 | EFO_0010093 | |
| Disease | prostate cancer (implicated_via_orthology) | 1.93e-03 | 33 | 58 | 2 | DOID:10283 (implicated_via_orthology) |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GEEIGPGAYVYLYII | 226 | Q14264 | |
| YNYNPYIGGLGIPVA | 2531 | Q9NR09 | |
| VQLYQVGEVRPFYYG | 276 | O43505 | |
| YYLGGYCFPALVVGI | 966 | O94910 | |
| VIYQVGLIPSQYYGV | 56 | O14678 | |
| TYLPQYGGYGAGQSV | 966 | Q5TGY3 | |
| GIQPDPYYGLKYIGV | 131 | Q8WUJ3 | |
| GYVTAGGYGYAVQQP | 186 | Q9BX46 | |
| PYAEYLQVVNYGIGG | 421 | Q7Z4N8 | |
| PVAGYQYGQYGQTAV | 456 | P23759 | |
| QIYDVGYQYGKAVFG | 1241 | Q8IY17 | |
| VYISGGHDYQIGPYR | 446 | Q8N4N3 | |
| LLEVGTYEGNYYGTP | 176 | Q96QZ7 | |
| TGGYVYRGCEYPNLN | 476 | Q96JK4 | |
| VEDLRLAYGGGYYQN | 351 | Q6ZUT3 | |
| GVPPYDSVQVYGYEG | 756 | Q86UP0 | |
| GFPHVENGRIAQYYY | 26 | P05160 | |
| LNEPFVIAYQGYGYG | 1536 | P09848 | |
| VIAYQGYGYGTAAPG | 1541 | P09848 | |
| VYAGSHQYPGRGVYL | 491 | Q9H3P7 | |
| AYLNGYIYILGGRDP | 431 | Q8WVZ9 | |
| VQPLYYDYYGGEVGE | 351 | Q6PEW0 | |
| LIGYGTLPYFYGNVG | 401 | Q9C091 | |
| RYPYEYLGGHIQGAL | 331 | P30307 | |
| GIGYFYGQGLVLPDI | 401 | Q13724 | |
| AYTVLLYGNGPGYVL | 406 | P10696 | |
| VYIYHGDAGGIVPQY | 396 | Q13797 | |
| HTYNTYIGQGYIIPG | 311 | Q96AY3 | |
| GAYYIPGQGRSTYVV | 101 | Q04637 | |
| RFQAEGGYVLYPQIG | 41 | Q15768 | |
| SYVVDGQRIIYGPAY | 81 | Q00888 | |
| SYVVDGQIIIYGPAY | 81 | Q9UQ72 | |
| FYGYIITQIPGGYVA | 116 | Q9NRA2 | |
| PYYVYNIIGGLDEEG | 131 | P20618 | |
| AYLNGYIYILGGRDP | 431 | Q86V97 | |
| SYVVDGQIIIYGPAY | 81 | Q16557 | |
| GYINGTAEAVYVPGY | 66 | Q9GZV3 | |
| PIPAYGGVVYQDGFY | 291 | Q9NWB1 | |
| KVYPDGNGVVRGYYL | 311 | O94972 | |
| YIKQLGGGYYVFPGA | 146 | Q9Y3Z3 | |
| GGDCYIILYTYPRGQ | 421 | Q9Y6U3 | |
| EYYYPKQQGLRGTFG | 571 | P21675 | |
| SYVVDGQIIIYGPAY | 81 | Q9UQ74 | |
| RGVTLPGAYQGIIYY | 256 | P48065 | |
| TGRVQGYEGYYVLPV | 2736 | Q9NT68 | |
| YGLPYALYAQGQEGR | 726 | O15047 | |
| ICGYGYYGNDPTDLI | 226 | Q9UHF7 | |
| PGYGVGKQDVYYGVA | 371 | A1L020 | |
| TYGHVPNGGRVYYLQ | 206 | O43280 | |
| VGGGNYIEYQNLVDY | 596 | Q8WVM8 | |
| IDYPVLYGKYLNGLG | 106 | Q8N2W9 | |
| QPVSGVDYYEGGYRN | 81 | Q96JE7 | |
| KGYVQQGVYSRGGYP | 101 | Q8NF64 | |
| SYVVDGQIIIYGPAY | 81 | P11465 | |
| EAVGAGGGPIYYIYE | 51 | Q96MF2 | |
| SYVVDGQINIYGPAY | 81 | Q15238 | |
| QAVGGGLLYYAFPYI | 206 | Q9P055 | |
| LPIYGQDVIYTYSGQ | 116 | Q9ULV0 | |
| TGYYVNYREVIDGVP | 966 | P52179 |